AACE 2026: Basal-Based Insulin Improves Inpatient Glycemic Control in T2DM Tags Hyperglycemia hyperosmolar state Long acting Read more about AACE 2026: Basal-Based Insulin Improves Inpatient Glycemic Control in T2DM
AACE 26: Synthetic Semaglutide Delivers Similar HbA1c, Weight Outcomes in T2DM Tags GLP-1 agonists PLBS hBA1c Read more about AACE 26: Synthetic Semaglutide Delivers Similar HbA1c, Weight Outcomes in T2DM
Brolucizumab Improves BCVA Compared With PRP in PDR Tags Retinopathy Read more about Brolucizumab Improves BCVA Compared With PRP in PDR
T Cell Immunotherapy Preserves β-Cell Function in New-Onset T1DM Read more about T Cell Immunotherapy Preserves β-Cell Function in New-Onset T1DM
Early AID Adoption in New-Onset T1DM Shows Low Hypoglycemia Burden Tags Diabetic ketoacidosis Hypoglycemia Insulin Pumps Others Delivery devices Continuous glucose monitoring (CGM) Read more about Early AID Adoption in New-Onset T1DM Shows Low Hypoglycemia Burden
AACE 2026: LSM Declines Across Fibrosis Stages With Empagliflozin Tags SGLT-2 Inhibitor Read more about AACE 2026: LSM Declines Across Fibrosis Stages With Empagliflozin
AACE 2026: Inpatient Glycemia Improves With Insulin Pump Continuation Tags Hypoglycemia Insulin Pumps Read more about AACE 2026: Inpatient Glycemia Improves With Insulin Pump Continuation
Prolonged Glucose Excursions Drive GMI-HbA1c Discordance in T1DM Tags hBA1c Continuous glucose monitoring (CGM) Read more about Prolonged Glucose Excursions Drive GMI-HbA1c Discordance in T1DM
Adolescent Perspectives Highlight Low Burden With SGLT2i Adjunct Therapy Tags SGLT-2 Inhibitor Read more about Adolescent Perspectives Highlight Low Burden With SGLT2i Adjunct Therapy
AACE 2026: Tirzepatide Leads HbA1C Reduction, Semaglutide Leads Weight Loss Tags hBA1c GLP-1 agonists Read more about AACE 2026: Tirzepatide Leads HbA1C Reduction, Semaglutide Leads Weight Loss
